Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Haemonetics Corporation (HAE)

-NYSE
33.21 Up 0.19(0.58%) Apr 17, 4:01PM EDT
|After Hours : 33.02 Down 0.19 (0.57%) Apr 17, 4:59PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Mar 31, 2012Apr 2, 2011
Total Revenue 891,990   727,844   676,694  
Cost of Revenue463,859  358,604  321,485  
Gross Profit 428,131   369,240   355,209  
Operating Expenses
Research Development44,394  36,801  32,656  
Selling General and Administrative323,053  243,681  212,005  
Non Recurring4,247   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 56,437   88,758   110,548  
Income from Continuing Operations
Total Other Income/Expenses Net(6,540)740  (467)
Earnings Before Interest And Taxes49,897  89,498  110,081  
Interest Expense -   -   -  
Income Before Tax49,897  89,498  110,081  
Income Tax Expense11,097  22,612  30,101  
Minority Interest -   -   -  
Net Income From Continuing Ops38,800  66,886  79,980  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 38,800   66,886   79,980  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 38,800   66,886   79,980  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.